Press Release: Innventure Reports Second Quarter 2026 Results

Dow Jones
Aug 14

ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Innventure, Inc. $(INV)$ ("Innventure"), an industrial growth conglomerate, today announced financial results for the quarter ended June 30, 2026.

The company continues to anticipate significant long--term demand for two--phase liquid cooling as AI infrastructure requirements accelerate and is focused on executing against the foundational milestones expected to govern scaled market adoption of this technology. These milestones include chip-maker relationships and reference designs, OEM and ODM co-development initiatives, relationships with hyperscalers and the delivery of additional thermal benchmark data.

"We firmly believe the industry is moving toward a future where two-phase liquid cooling becomes an essential part of AI infrastructure, " said Bill Haskell, Chief Executive Officer. "While our conviction in Accelsius' long--term opportunity has only strengthened, evolving dynamics in the AI infrastructure market, including constraints facing smaller early adopters around power availability, GPU access, and deployment timing, have impacted our near-term expectations and render 2026 revenue generation an imprecise reflection of the meaningful progress Accelsius is making. As a result, we are suspending our previously communicated expectations regarding Accelsius' 2026 revenue and cash flow targets and shifting our focus to execution against important milestones that govern scaled market adoption, which include forging strong relationships with industry leaders. In light of our expectations regarding Accelsius' ability to make progress against these milestones and the momentum we are seeing at AeroFlexx and Refinity, we believe Innventure is well positioned to create shareholder value over the long term."

Conference Call and Webcast

A conference call to discuss these results has been scheduled for 5:00 pm ET today, August 13, 2026.

The event will be webcasted live via our investor relations website https://ir.innventure.com/ or via https://innventure-2q26-earnings.open-exchange.net/.

Innventure has posted a slide presentation to accompany the prepared remarks to its investor relations website https://ir.innventure.com/.

About Innventure

Innventure, Inc. (NASDAQ: INV), an industrial growth conglomerate, focuses on building companies with billion-dollar valuations by commercializing breakthrough technology solutions. By systematically creating and operating industrial enterprises from the ground up, Innventure participates in early-stage economics and provides industrial operating expertise designed for global scale. Innventure's approach seeks to uniquely bridge the "Valley of Death" between corporate innovation and commercialization through its distinctive combination of value-driven multinational partnerships, operational experience, and scaling expertise.

Non-GAAP Financial Measures

We use certain financial measures that are not calculated in accordance with generally accepted accounting principles in the U.S. (GAAP) to supplement our consolidated financial statements. These non-GAAP financial measures provide additional information to investors to facilitate comparisons of past and present operating results, identify trends in our underlying operating performance, and offer greater transparency on how we evaluate our business activities. These measures are integral to our processes for budgeting, managing operations, making strategic decisions, and evaluating our performance.

Our primary non-GAAP financial measures are EBITDA and Adjusted EBITDA. We define EBITDA as net income before interest, income taxes, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA further adjusted to exclude certain non-cash items, non-recurring expenses, and other items that are not indicative of our core operating activities. These may include stock-based compensation, acquisition costs, and other financial items. We believe Adjusted EBITDA is valuable for investors and analysts as it provides additional insight into our operational performance, excluding the impacts of certain financing, investing, and other non-operational activities. This measure helps in comparing our current operating results with prior periods and with those of other companies in our industry. It is also used internally for allocating resources efficiently, assessing the economic outcomes of acquisitions and strategic decisions, and evaluating the performance of our management team.

There are limitations to Adjusted EBITDA, including its exclusion of cash expenditures, future requirements for capital expenditures and contractual commitments, and changes in or cash requirements for working capital needs. Adjusted EBITDA also omits significant interest expenses and related cash requirements for interest and payments. While depreciation and amortization are non-cash charges, the associated assets will often need to be replaced in the future, and Adjusted EBITDA does not reflect the cash required for such replacements. Additionally, Adjusted EBITDA does not account for income or other taxes or necessary cash tax payments.

Investors should use caution when comparing our non-GAAP measure to similar metrics used by other companies, as definitions can vary. Adjusted EBITDA should not be considered in isolation or as a substitute for GAAP financial measures.

In presenting Adjusted EBITDA, we aim to provide investors with an additional tool for assessing the operational performance of our business. It serves as a useful complement to our GAAP results, offering a more comprehensive understanding of our financial health and operational efficiencies.

Cautionary Statement Regarding Forward-Looking Statements

Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are often identified by future or conditional words such as "plan," "believe," "expect," "anticipate," "intend," "outlook," "estimate," "forecast," "project," "continue," "could," "may," "might," "possible," "will," "potential," "predict," "should," "would" and other similar words and expressions (or the negative versions of such words or expressions), but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements are based on the current assumptions and expectations of future events that are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of this press release. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.

These risks and uncertainties include, but are not limited to, those factors described in Innventure's public filings with the U.S. Securities and Exchange Commission, including but not limited to the following: Innventure's and its subsidiaries' ability to execute on their strategies, book sales and achieve future financial performance; developments and projections relating to Innventure's and its subsidiaries' competitors and industry; the implementation, adoption, market acceptance and success of Innventure's and its subsidiaries' products, business models and growth strategies; Innventure's and its subsidiaries' ability to generate sufficient revenue and operating cash flow; the timing and magnitude of expected cash expenditures; the availability, timing and terms of additional financing, including debt or equity financing; market conditions affecting access to capital; potential dilution resulting from future financings; Innventure's ability to successfully implement cost reduction initiatives; changes in economic conditions; competitive pressures; regulatory developments; Innventure's ability to maintain control over its subsidiaries.

Forward--looking statements speak only as of the date of this release, and Innventure undertakes no obligation to update them except as required by law.

Investor Relations Contact: Kyle Nagarkar, Solebury Strategic Communications

investorrelations@innventure.com

Media Contact: Stephanie Knight, Solebury Strategic Communications

press@innventure.com

 
                    Innventure, Inc. and Subsidiaries 
                        Consolidated Balance Sheets 
                   (in thousands, except share amounts) 
 
                                     June 30, 2026     December 31, 2025 
                                    ---------------  --------------------- 
Assets 
     Cash and cash equivalents       $      41,543    $          60,449 
     Restricted cash                         5,000                5,000 
     Accounts receivable                     2,119                1,094 
     Due from related parties               16,351               11,840 
     Inventories                             2,989                1,604 
     Prepaid expenses and other 
      current assets                         3,437                3,167 
                                        ----------       -------------- 
Total Current Assets                        71,439               83,154 
     Investments                            26,644               28,741 
     Property, plant and 
      equipment, net                         2,269                1,941 
     Intangible assets, net                149,729              160,537 
     Goodwill                              323,463              323,463 
     Other assets                            1,153                1,351 
                                        ----------       -------------- 
Total Assets                         $     574,697    $         599,187 
Liabilities and Stockholders' 
Equity 
     Accounts payable                $       1,932    $           2,551 
     Accrued employee benefits               4,977               11,343 
     Accrued expenses                        1,959                7,386 
     Contract liabilities                      534                  947 
     Notes payable - current                 7,700               12,846 
     Term convertible note, 
      current                                8,026                7,890 
     Convertible promissory note, 
      current                                4,407                4,331 
     Patent installment payable - 
      current                                  825                  700 
     Obligation to issue equity                 73                  119 
     Warrant liability                      28,683               27,458 
     Income taxes payable                       18                   23 
     Other current liabilities                 633                  682 
                                        ----------       -------------- 
Total Current Liabilities                   59,767               76,276 
   Notes payable, net of current 
    portion                                  5,909                8,327 
   Earnout liability                         4,790                3,890 
   Stock-based compensation 
    liability                                  213                  239 
   Patent installment payable, net 
    of current                              11,550               12,375 
   Deferred income taxes                     9,264               13,848 
   Other liabilities                           389                  556 
                                        ----------       -------------- 
Total Liabilities                           91,882              115,511 
Commitments and Contingencies 
(Note 16) 
Stockholders' Equity 
   Preferred stock, $0.0001 par 
   value, 25,000,000 shares 
   authorized; 
     Series B Preferred Stock, 
     $0.0001 par value, 3,000,000 
     shares designated, 24,779 and 
     33,144 shares issued and 
     outstanding as of June 30, 
     2026 and December 31, 2025, 
     respectively.                              --                   -- 
     Series C Preferred Stock, 
     $0.0001 par value, 5,000,000 
     shares designated, 159,270 
     shares issued and outstanding 
     as of June 30, 2026 and 
     150,000 shares issued and 
     outstanding as of December 
     31, 2025.                                  --                   -- 
   Common Stock, $0.0001 par 
    value, 250,000,000 shares 
    authorized, 84,612,657 and 
    67,743,847 shares issued and 
    outstanding as of June 30, 
    2026 and December 31, 2025, 
    respectively.                                8                    7 
   Additional paid-in capital              632,237              577,070 
   Accumulated other comprehensive 
    gain (loss)                               (644)              (1,260) 
   Accumulated deficit                    (418,911)            (371,603) 
                                        ----------       -------------- 
Total Innventure, Inc., 
 Stockholders' Equity                      212,690              204,214 
   Non-controlling interest                270,125              279,462 
                                        ----------       -------------- 
Total Stockholders' Equity                 482,815              483,676 
                                        ----------       -------------- 
Total Liabilities and 
 Stockholder's Equity                $     574,697    $         599,187 
                                        ----------       -------------- 
 
 
 
                       Innventure, Inc. and Subsidiaries 
             Consolidated Statements of Operations and Comprehensive 
                                  Income (Loss) 
               (in thousands, except share and per share amounts) 
 
                        Three Months  Three Months   Six Months     Six Months 
                         Ended June    Ended June    Ended June   Ended June 30, 
                          30, 2026      30, 2025      30, 2026         2025 
                        ------------  ------------  ------------  -------------- 
Revenue                 $       953   $       476   $     2,396   $       700 
 
Operating Expenses 
    Cost of sales             5,073         2,861        10,326         3,045 
    General and 
     administrative          14,499        18,569        27,249        38,245 
    Sales and 
     marketing                3,089         2,208         5,986         4,304 
    Research and 
     development              9,780         6,068        17,620        12,321 
    Goodwill 
     impairment                  --       113,344            --       346,557 
                         ----------    ----------    ----------    ---------- 
Total Operating 
 Expenses                    32,441       143,050        61,181       404,472 
 
Loss from Operations        (31,488)     (142,574)      (58,785)     (403,772) 
 
Non-operating 
(Expense) and Income 
      Interest 
       expense, net            (531)       (2,647)       (1,520)       (4,185) 
      Net gain (loss) 
       from 
       investments               39            --           108            -- 
      Change in fair 
       value of 
       financial 
       liabilities           (2,188)        7,176        (2,125)       23,605 
      Equity method 
       investment 
       (loss) income         (1,491)       (1,924)       (3,007)       (8,680) 
      Realized gain on 
       conversion of 
       available for 
       sale 
       investment                --            --            --         1,507 
      Loss on 
       extinguishment 
       of debt                   --        (3,462)         (977)       (3,462) 
      Loss on 
       extinguishment 
       of related 
       party debt                --            --            --        (3,538) 
      Miscellaneous 
       other expense           (773)          (64)         (948)          (43) 
                         ----------    ----------    ----------    ---------- 
Total Non-operating 
 Income (Expense)            (4,944)         (921)       (8,469)        5,204 
                         ----------    ----------    ----------    ---------- 
Loss before Income 
 Taxes                      (36,432)     (143,495)      (67,254)     (398,568) 
      Income tax 
       benefit               (1,518)       (2,220)       (4,557)       (3,619) 
                         ----------    ----------    ----------    ---------- 
Net Loss                    (34,914)     (141,275)      (62,697)     (394,949) 
     Less: net loss 
     attributable to 
      Non-redeemable 
       non-controlling 
       interest              (8,411)      (57,048)      (15,389)     (167,725) 
                         ----------    ----------    ----------    ---------- 
Net Loss Attributable 
 to Innventure, Inc. 
 Stockholders / 
 Innventure LLC 
 Unitholders                (26,503)      (84,227)      (47,308)     (227,224) 
                         ----------    ----------    ----------    ---------- 
 
      Basic and 
       diluted loss 
       per share        $     (0.32)  $     (1.60)  $     (0.59)  $     (4.60) 
      Basic and 
       diluted 
       weighted 
       average common 
       shares            83,117,031    52,546,491    83,117,031    49,417,092 
 
 
 
Innventure, Inc. and Subsidiaries 
 Consolidated Statements of Cash Flows 
 (in thousands) 
 
                                Three Months Ended      Three Months Ended 
                                   June 30, 2026           June 30, 2025 
                              ----------------------  ---------------------- 
Cash Flows Used in Operating 
Activities 
    Net loss                   $         (62,697)      $         (394,949) 
   Adjustments to reconcile 
   net loss to net cash used 
   in operating activities: 
    Stock-based compensation              10,309                   15,247 
    Interest income on debt 
     securities - related 
     party                                  (180)                    (195) 
    Change in fair value of 
     financial liabilities                 2,125                  (23,605) 
    Non-cash interest 
     expense on notes 
     payable                               1,119                    2,560 
    Net gain on investments                 (107)                      -- 
    Accrued unpaid interest 
    on note payable                          238                       -- 
    Equity method investment 
     loss (income)                         3,006                    8,680 
    Realized gain on 
     conversion of available 
     for sale investments                     --                   (1,507) 
    Loss on extinguishment 
     of debt                                 977                    3,462 
    Loss on extinguishment 
     of related party debt                    --                    3,538 
    Deferred income taxes                 (4,585)                  (3,897) 
    Loss on Disposal of PPE                  223                       -- 
    Depreciation and 
     amortization                         11,331                   11,182 
    Goodwill impairment                       --                  346,557 
    Other costs, net                       1,100                      165 
  Changes in operating 
  assets and liabilities: 
    Accounts receivable                   (1,025)                    (618) 
    Prepaid expenses and 
     other current assets                 (4,779)                  (3,312) 
    Inventory                             (1,385)                  (1,442) 
    Accounts payable                        (619)                     315 
    Accrued employee 
     benefits                             (6,365)                   1,330 
    Accrued expenses                      (6,722)                      42 
    Stock-based compensation 
     liability                               (26)                    (686) 
    Income taxes payable                      (5)                     292 
    Other current 
     liabilities                            (286)                     (78) 
    Contract liabilities                    (413)                     690 
    Patent installment 
     payable                                (700)                    (525) 
Net Cash Used in Operating 
 Activities                              (59,466)                 (36,754) 
                                  --------------          --------------- 
 
Cash Flows (Used in) 
Provided by Investing 
Activities 
    Investment in 
     available-for-sale debt 
     securities - equity 
     method investee                          --                   (2,708) 
    Acquisition of property, 
     plant and equipment                  (1,074)                    (932) 
Net Cash (Used in) Provided 
 by Investing Activities                  (1,074)                  (3,640) 
                                  --------------          --------------- 
 
Cash Flows Provided by 
Financing Activities 
    Proceeds from issuance 
     of equity, net of 
     issuance costs                       50,229                    3,675 
    Proceeds from the 
     issuance of equity to 
     non-controlling 
     interest, net of 
     issuance costs                           --                    5,367 
    Proceeds from the 
     issuance of convertible 
     promissory note                          --                    3,999 
    Proceeds from the 
     issuance of term 
     convertible notes                        --                    2,451 
    Proceeds from issuance 
     of debt securities, net 
     of issuance costs                        --                   27,000 
    Payment of debts                      (8,595)                  (1,176) 
    Distributions to 
     Stockholders                             --                      (76) 
Cash Flows Provided by 
 Financing Activities                     41,634                   41,240 
                                  --------------          --------------- 
 
Net Decrease in Cash, Cash 
 Equivalents and Restricted 
 Cash                                    (18,906)                     846 
                                  --------------          --------------- 
  Cash, Cash Equivalents and 
   Restricted Cash Beginning 
   of period                              65,449                   11,119 
                                  --------------          --------------- 
Cash, Cash Equivalents and 
 Restricted Cash End of 
 period                        $          46,543       $           11,965 
                                  --------------          =============== 
 
 
Supplemental Cash Flow Information 
    Cash paid for interest                           $1,097  $ 1,825 
Supplemental Disclosure of Noncash Financing 
Information 
    Conversion of working capital loans to equity 
     method investee into investments in debt 
     securities - related party                          --    4,375 
    Unrealized gain on investments in debt 
    Securities - related party through OCI              623       -- 
    Extinguishment of debt with Series C Preferred 
     Stock                                               --   14,000 
    Contribution of Series C Preferred Stock to 
     equity method investee                              --    5,783 
    Conversion of AFX available-for-sale term loan 
     into equity method investments                      --    8,757 
    Issuance of common stock as repayment of 
     convertible debt                                 1,090    2,533 
    Issuance of vested RSUs                           1,276       -- 
    Issuance of stock in exchange for services           11    4,095 
    Equity reallocation between non-controlling 
     interest and additional paid-in capital             --   25,268 
 
 
 
Innventure, Inc. and Subsidiaries 
 Non-GAAP Financial Measures 
 (in thousands) 
 
                     Three                   Six 
                    Months      Three      Months 
                     Ended      Months      Ended    Six Months 
                   June 30,   Ended June  June 30,   Ended June 
                     2026      30, 2025     2026      30, 2025 
                   ---------  ----------  ---------  ----------- 
Net loss           $(34,914)  $(141,275)  $(62,697)  (394,949) 
Interest expense, 
 net(1)                 531       2,647      1,520      4,185 
Depreciation and 
 amortization 
 expense              5,660       5,634     11,331     11,182 
Income tax 
 expense 
 (benefit)           (1,518)     (2,220)    (4,557)    (3,619) 
EBITDA              (30,241)   (135,214)   (54,403)  (383,201) 
                    -------    --------    -------   -------- 
Change in fair 
 value of 
 financial 
 liabilities((2) 
 ()                   2,188      (7,176)     2,125    (23,605) 
Stock-based 
 compensation((3) 
 ()                   5,477       9,406     10,309     15,247 
Goodwill 
 impairment((4) 
 ()                      --     113,344         --    346,557 
Loss on 
 extinguishment 
 of debt((5) ()          --       3,462        977      3,462 
Loss on 
 extinguishment 
 of related party 
 debt(6)                 --          --         --      3,538 
Adjusted EBITDA     (22,576)    (16,178)   (40,992)   (38,002) 
                    =======    ========    =======   ======== 
 
 
(1)  Interest Expense, net, includes interest incurred 
      on our various borrowing facilities and the amortization 
      of debt issuance costs. 
(2)  Change in fair value of financial liabilities -- For 
      the three and six months ended June 30, 2026, and 
      2025, the change in fair value of financial liabilities 
      primarily consists of the change in fair value of 
      the warrant liability, the earnout liability and the 
      embedded derivatives in various instruments. 
(3)  Stock based compensation -- For the three and six 
      months ended June 30, 2026, and 2025, stock based 
      compensation primarily consisted of awards in the 
      2024 Equity and Incentive Plan. These awards consisted 
      of Stock Options, Restricted Stock Units, and Stock 
      Appreciation Rights. Further, a portion of this expense 
      was related to share-based payment employee incentive 
      plans in existence at subsidiaries. 
(4)  Goodwill impairment - For the three and six months 
      ended June 30, 2025, the Company recognized goodwill 
      impairment due to sustained decreases in the Company's 
      publicly quoted share price and market capitalization, 
      which were, at least in part, sensitive to the general 
      downward volatility experienced in the stock market 
      in the comparable period in the prior year. There 
      was no goodwill impairment for the three and six months 
      ended June 30, 2026. 
(5)  Loss on extinguishment of debt - For the six months 
      ended June 30, 2026, the Company repaid the Convertible 
      Debentures, which resulted in an aggregate of $1.0 
      million loss on extinguishment of debt. There was 
      no loss on extinguishment of debt for the three months 
      ended June 30, 2026. For the three and six months 
      ended June 30, 2025, the Company recognized a loss 
      on extinguishment of debt of $3.5 million in connection 
      with the modification of the WTI Facility. 
(6)  Loss on extinguishment of related party debt - For 
      the six months ended June 30, 2025, the Company extinguished 
      certain related party debts by issuing Series C Preferred 
      Stock. There was no loss on extinguishment of related 
      party debt for the three months ended June 30, 2026. 
 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10